Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

J&J’s Tremfya shows significant improvements for post-TNFi psoriatic arthritis patients

pharmatimesJune 04, 2021

Tag: J&J , TREMFYA , interleukin-23 , PSA

PharmaSources Customer Service